drugset / Trial / NCT02133625
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Non-randomizedSingle-groupTreatment
Summary
The proposed investigation is a Phase 1 trial to determine the safety, tolerability, and maximum tolerated dose (MTD) of the combination of pioglitazone ( and carboplatin patients with advanced or metastatic solid malignancies.
Timeline
- Start
- 2011-08
- Primary completion
- 2016-03
- Completion
- 2026-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |